Role of PTCH1 gene methylation in gastric carcinogenesis
- Authors:
- Yun Zuo
- Yu Song
- Min Zhang
- Zhen Xu
- Xiaolan Qian
View Affiliations
Affiliations: Department of Oncology, The First Hospital of Zhangjiagang, Zhangjiagang, Jiangsu 215600, P.R. China
- Published online on: May 26, 2014 https://doi.org/10.3892/ol.2014.2178
-
Pages:
679-682
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The present study aimed to investigate the role of PTCH1 methylation in gastric carcinogenesis and the therapeutic effect of the methylation inhibitor, 5‑aza‑2'‑deoxycytidine (5‑aza‑dC), in the treatment of gastric cancer. Total RNA was extracted from 20 gastric cancer tissues, their corresponding adjacent normal tissues and a gastric cancer AGS cell line. PTCH1 mRNA expression was detected by quantitative PCR, and the PTCH1 methylation of the promoter was examined by methylation‑specific PCR. The AGS cells were treated with 5‑Aza‑dC; apoptosis and the cell cycle were examined by flow cytometry, and the PTCH1 methylation level was observed. PTCH1 expression was negatively correlated with promoter methylation in the gastric cancer tissues, their corresponding adjacent normal tissues and the gastric cancer AGS cell line (r=‑0.591, P=0.006). 5‑Aza‑dC treatment caused apoptosis and the G0/G1 phase arrest of the AGS cells, and also induced the demethylation and increased expression of PTCH1. In conclusion, the study found that the hypermethylation of the PTCH1 gene promoter region is one of the main causes of low PTCH1 expression in AGS cells. Demethylation agent 5‑Aza‑dC can reverse the methylation status of PTCH1 and regulate the expression of PTCH1, indicating its potential role in gastric cancer treatment.
View References
|
1
|
Saqui-Salces M and Merchant JL: Hedgehog
signaling and gastrointestinal cancer. Biochim Biophys Acta.
1803:786–795. 2010.
|
|
2
|
Shahi MH, Lorente A and Castresana JS:
Hedgehog signaling in medulloblastoma, glioblastoma and
neuroblastoma. Oncol Rep. 19:681–688. 2008.
|
|
3
|
Cul’bová M, Lasabová Z, Stanclová A, et
al: Methylation of selected tumor-suppressor genes in benign and
malignant ovarian tumors. Ceska Gynekol. 76:274–279. 2011.(In
Slovak).
|
|
4
|
Zuo Y and Song Y: Detection and analysis
of the methylation status of PTCH1 gene involved in the hedgehog
signaling pathway in a human gastric cancer cell line. Exp Ther
Med. 6:1365–1368. 2013.
|
|
5
|
Tada M, Kanai F, Tanaka Y, et al:
Down-regulation of hedgehog-interacting protein through genetic and
epigenetic alterations in human hepatocellular carcinoma. Clin
Cancer Res. 14:3768–3776. 2008.
|
|
6
|
Caffarelli E and Filetici P: Epigenetic
regulation in cancer development. Front Biosci (Landmark Ed).
16:2682–2694. 2011.
|
|
7
|
To KF, Leung WK, Lee TL, et al: Promoter
hypermethylation of tumor-related genes in gastric intestinal
metaplasia of patients with and without gastric cancer. Int J
Cancer. 102:623–628. 2002.
|
|
8
|
Watkins DN, Berman DM, Burkholder SG, et
al: Hedgehog signalling within airway epithelial progenitors and in
small-cell lung cancer. Nature. 422:313–317. 2003.
|
|
9
|
Ma X, Sheng T, Zhang Y, et al: Hedgehog
signaling is activated in subsets of esophageal cancers. Int J
Cancer. 118:139–148. 2006.
|
|
10
|
Taniguchi H, Yamamoto H, Akutsu N, et al:
Transcriptional silencing of hedgehog-interacting protein by CpG
hypermethylation and chromatic structure in human gastrointestinal
cancer. J Pathol. 213:131–139. 2007.
|
